TransMolecular, Inc.: An Oncology Focused Biotechnology Company
 
Pursuing Cures for Cancer Through Targeted Therapy
   


upcoming events

American Society for Therapeutic Radiology and Oncology (ASTRO)
49th Annual Meeting

October 28 - November 1, 2007
Los Angeles Convention Center
Los Angeles, CA

Transmolecular will be presenting an abstract on clinical trial TM601-003 – a study evaluating specific localization of tumors by IV-administered, radio-labeled TM-601 in patients with primary and metastatic cancers.

Society for Neuro-oncology
12th Annual Scientific Meeting

Nov 15-18, 2007, Dallas, TX

Transmolecular will be presenting an abstract on interim results from clinical trial TM601-002, a phase II trial evaluating radio-labeled TM-601 in the treatment of high grade glioma.


media relations | press releases | abstracts & articles | in the news | events | company overview | research & development | investors | additional resources

 

 

 

company overview | management | board of directors | investors | medical advisory board | product pipeline | publications & abstracts | completed glioma clinical trials | ongoing clinical trials | future directions | currently recruiting | media relations | press releases | abstracts & articles | in the news | events | research & development | additional resources | advancing targeted cancer therapy | clinical trials | disease information | news | about glioma | glioma | other primary brain tumors | metastatic brain tumors | contact us | careers | site map